Class I Recall For Integra’s CereLink Intracranial Pressure Monitors
Executive Summary
The US FDA has labelled a June recall of intracranial pressure monitors from Integra with its most serious designation, class I.
You may also be interested in...
Integra LifeSciences Recalls Products From Boston Facility, Takes Financial Hit
After consulting with the US FDA, Integra Life Sciences initiated a recall of products produced in its Boston Facility. The company expects losses of $22m.
Integra Issues Recall Of Intracranial Pressure Monitors
Integra LifeSciences has recalled CereLink intracranial pressure monitors because of reports they were providing inaccurate readings. The company adjusted its third quarter earnings expectations in response.
Alarming Rise Of Diabetes in Several US States, Study Shows
A study of diabetes rates across the US over four years reveals significant increases in the disease in many states. Tobias Oerum, diabetes advocate and cofounder of the company that conducted the study, discussed the data and some of the factors contributing to this troubling trend with Medtech Insight.